CX3CL1 expression increases in the heart and serum of patients with end-stage heart failure due to coronary artery disease or dilated cardiomyopathy [29], which involves however different mechanisms from the compensated hypertrophy due to arterial hypertension or aortic stenosis. Here, CX3CL1 is linked to coronary artery disorder.